US limits use of J&J's COVID-19 vaccine for adults on blood clot risks - CNA

The US health regulator said on Thursday (May 5) it was limiting the use of Johnson & Johnson's COVID-19 vaccine for adults due to the risk of a rare blood clotting syndrome, the latest setback to the shot that has been eclipsed by rivals. The J&J shot, wh…

The US health regulator said on Thursday (May 5) it was limiting the use of Johnson & Johnson's COVID-19 vaccine for adults due to the risk of a rare blood clotting syndrome, the latest setback t… [+1792 chars]

full article...